Researchers Suggest Changes to FDA Oversight of AI Breast Cancer Screening
- In a special communication published this week in JAMA Internal Medicine, Yale researchers explore the current regulatory processes for artificial intelligence (AI)-based breast cancer screening tools, sharing the limitations, advantages, and potential recommendations for improvement in US Food and Drug Administration (FDA) regulatory...
